<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has completed the integration of Creso ImpACTIVE Ltd’s assets into its product portfolio in a move that should help CPH increase its North American footprint and broaden its range of leading CBD products. CPH has now made excellent progress in strengthening its IP position around the new products and started stability testing protocols.
...read full article on Proactive Investors
